Organon

The page provides news, announcements, and resources from Organon.

Merck announced Matthew Walsh as chief financial officer and Rachel Stahler as chief information officer of Organon & Co., its intended spinoff of women’s health, legacy brands, and biosimilars businesses.

Merck, known as MSD outside the United States and Canada, appointed Deborah H. Telman as General Counsel for Organon & Co., its intended spinoff of its women’s health, legacy brands and biosimilars businesses.

Merck announced that Organon & Co. would be the name of a new company planned through the spinoff of its women’s health, legacy brands, and biosimilars businesses. Organon had been part of Merck since its 2009 Schering-Plough acquisition.

Organon is a global health company working to shape the future of women’s health care.

Organon’s corporate headquarters is in Jersey City, NJ, USA.

Organon is a global health care company dedicated to making a world of difference for women, their families and the communities they care for.

Organon Sweden AB is identified as the data controller responsible for collecting and processing personal data. Processing is for purposes in Organon’s Privacy Policy, and stated legal bases include necessity for contract performance.

The data controller for personal data is Organon Pharma B.V., Oss Ljubljana Branch, at Trg Republike 3, Floor 3, 1000 Ljubljana, Slovenia. Processing purposes are set out in the Privacy Policy.

Organon BH d.o.o. is identified as the data controller responsible for collecting and processing personal data. Processing is for purposes in Organon’s Privacy Policy, and stated legal bases include necessity for contract performance.

The notice identifies Organon (I.A.) BV – Bulgaria Branch as a data controller and says personal information is processed for purposes set out in its Privacy Policy.